CURE spoke with a thoracic surgeon in regards to the influence of minimally invasive surgical procedure for sufferers.For sufferers with lung most cancers,...
The U.S. FDA has granted quick observe designation to therapy with CLD-201, an oncolytic virus, for sufferers with delicate tissue sarcoma.The U.S. Meals...
On June 23, 2025, the U.S. Meals and Drug Administration (FDA) granted accelerated approval to Datroway (datopotamab deruxtecan-dlnk) for the remedy of sufferers...
